Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model

被引:5
|
作者
Khalili, Dilan [1 ]
Kalcher, Christina [1 ]
Baumgartner, Stefan [2 ]
Theopold, Ulrich [1 ]
机构
[1] Stockholm Univ, Wenner Gren Inst MBW, Dept Mol Biosci, Stockholm, Sweden
[2] Lund Univ, Dept Expt Med Sci, Lund, Sweden
基金
瑞典研究理事会;
关键词
Fibrosis; Antimicrobial peptides; Insect immunity; Innate immunity; Extracellular matrix;
D O I
10.1159/000516104
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fibrotic lesions accompany several pathological conditions, including tumors. We show that expression of a dominant-active form of the Ras oncogene in Drosophila salivary glands (SGs) leads to redistribution of components of the basement membrane (BM) and fibrotic lesions. Similar to several types of mammalian fibrosis, the disturbed BM attracts clot components, including insect transglutaminase and phenoloxidase. SG epithelial cells show reduced apicobasal polarity accompanied by a loss of secretory activity. Both the fibrotic lesions and the reduced cell polarity are alleviated by ectopic expression of the antimicrobial peptide drosomycin (Drs), which also restores the secretory activity of the SGs. In addition to extracellular matrix components, both Drs and F-actin localize to fibrotic lesions.
引用
收藏
页码:376 / 390
页数:15
相关论文
共 50 条
  • [1] Strategies for anti-fibrotic therapies
    Rosenbloom, Joel
    Mendoza, Fabian A.
    Jimenez, Sergio A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (07): : 1088 - 1103
  • [2] Novel Anti-fibrotic Therapies
    McVicker, Benita L.
    Bennett, Robert G.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [3] Anti-fibrotic effects of the antihistamine ketotifen in a rabbit model of arthrofibrosis
    Tibbo, M. E.
    Limberg, A. K.
    Salib, C. G.
    Turner, T. W.
    McLaury, A. R.
    Jay, A. G.
    Bettencourt, J. W.
    Carter, J. M.
    Bolon, B.
    Berry, D. J.
    Morrey, M. E.
    Sanchez-Sotelo, J.
    van Wijnen, A. J.
    Abdel, M. P.
    BONE & JOINT RESEARCH, 2020, 9 (06): : 302 - 310
  • [4] Anti-fibrotic activity of Euglena gracilis and paramylon in a mouse model of non-alcoholic steatohepatitis
    Nakashima, Ayaka
    Sugimoto, Ryota
    Suzuki, Kengo
    Shirakata, Yuka
    Hashiguchi, Taishi
    Yoshida, Chikara
    Nakano, Yoshihisa
    FOOD SCIENCE & NUTRITION, 2019, 7 (01): : 139 - 147
  • [5] Anti-fibrotic therapy: Lost in translation?
    Schuppan, Detlef
    Pinzani, Massimo
    JOURNAL OF HEPATOLOGY, 2012, 56 : S66 - S74
  • [6] Optimizing Processing Technology of Cornus officinalis: Based on Anti-Fibrotic Activity
    Han, Xin
    Ding, Chuan
    Ning, Yan
    Shan, QiYuan
    Niu, Minjie
    Cai, Hao
    Xu, Peng
    Cao, Gang
    FRONTIERS IN NUTRITION, 2022, 9
  • [7] Progress in promising anti-fibrotic therapies
    Santoro, Rosanna
    Mangia, Alessandra
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (12) : 1145 - 1152
  • [8] Anti-fibrotic Actions of Roselle Extract in Rat Model of Myocardial Infarction
    Ali, Shafreena Shaukat
    Mohamed, Siti Fatimah Azaharah
    Rozalei, Nur Hafiqah
    Boon, Yap Wei
    Zainalabidin, Satirah
    CARDIOVASCULAR TOXICOLOGY, 2019, 19 (01) : 72 - 81
  • [9] Anti-fibrotic Actions of Roselle Extract in Rat Model of Myocardial Infarction
    Shafreena Shaukat Ali
    Siti Fatimah Azaharah Mohamed
    Nur Hafiqah Rozalei
    Yap Wei Boon
    Satirah Zainalabidin
    Cardiovascular Toxicology, 2019, 19 : 72 - 81
  • [10] Anti-fibrotic treatments for chronic liver diseases: The present and the future
    Odagiri, Naoshi
    Matsubara, Tsutomu
    Sato-Matsubara, Misako
    Fujii, Hideki
    Enomoto, Masaru
    Kawada, Norifumi
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (03) : 413 - 424